ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.374,53
1,22%
S&P 500
5.537,02
0,51%
Dow Jones
39.308,00
-0,06%
Euro vs US Dollar
1,07823
0,32%
Bitcoin
60.200,47
-2,95%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. XOMA Corporation (XOMAP)

  7. XOMA Corporation (XOMAP) News

XOMAP

XOMA (XOMAP)

XOMA Corporation
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:XOMAP
DatumZeitQuelleÜberschriftSymbolFirma
20/06/202413h30GlobeNewswire Inc.XOMA Declares Quarterly Preferred Stock DividendsNASDAQ:XOMAPXOMA Corporation
18/06/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:XOMAPXOMA Corporation
18/06/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:XOMAPXOMA Corporation
13/06/202422h31Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:XOMAPXOMA Corporation
12/06/202413h30GlobeNewswire Inc.XOMA Receives $8.1 Million Milestone Related to Day One Biopharmaceuticals’ Sale of its Priority Review VoucherNASDAQ:XOMAPXOMA Corporation
30/05/202422h43Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XOMAPXOMA Corporation
17/05/202422h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XOMAPXOMA Corporation
17/05/202422h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XOMAPXOMA Corporation
17/05/202422h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XOMAPXOMA Corporation
17/05/202422h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XOMAPXOMA Corporation
17/05/202422h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XOMAPXOMA Corporation
17/05/202422h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XOMAPXOMA Corporation
16/05/202413h31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XOMAPXOMA Corporation
14/05/202413h30GlobeNewswire Inc.XOMA to Present at H.C. Wainwright 2nd Annual Bioconnect Investor Conference at NASDAQNASDAQ:XOMAPXOMA Corporation
09/05/202413h45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XOMAPXOMA Corporation
09/05/202413h35Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:XOMAPXOMA Corporation
09/05/202413h30GlobeNewswire Inc.XOMA Reports First Quarter 2024 Financial Results and Highlights Recent ActivitiesNASDAQ:XOMAPXOMA Corporation
30/04/202413h30GlobeNewswire Inc.XOMA Adds Economic Interests in Three First-in-Category Assets to its Royalty and Milestone Portfolio Including XACIATO™ (clindamycin phosphate) Vaginal Gel 2%NASDAQ:XOMAPXOMA Corporation
25/04/202413h30GlobeNewswire Inc.XOMA Earns $9 Million Milestone as FDA Grants Accelerated Approval to Day One’s OJEMDATM (tovorafenib) for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG)NASDAQ:XOMAPXOMA Corporation
03/04/202415h00GlobeNewswire Inc.XOMA Corporation Announces Closing of Tender OfferNASDAQ:XOMAPXOMA Corporation
21/03/202412h30GlobeNewswire Inc.XOMA Declares Quarterly Preferred Stock DividendsNASDAQ:XOMAPXOMA Corporation
19/03/202421h05GlobeNewswire Inc.XOMA Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Kinnate Biopharma Inc.NASDAQ:XOMAPXOMA Corporation
11/03/202411h56Edgar (US Regulatory)Form S-4 - Registration of securities, business combinationsNASDAQ:XOMAPXOMA Corporation
08/03/202422h34Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:XOMAPXOMA Corporation
08/03/202413h39Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XOMAPXOMA Corporation
08/03/202413h30GlobeNewswire Inc.XOMA Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent and Upcoming Events Expected to Drive Shareholder ValueNASDAQ:XOMAPXOMA Corporation
04/03/202423h24Edgar (US Regulatory)Form SC TO-T - Tender offer statement by Third PartyNASDAQ:XOMAPXOMA Corporation
28/02/202413h30GlobeNewswire Inc.XOMA to Present at Upcoming Investor Conferences in MarchNASDAQ:XOMAPXOMA Corporation
16/02/202415h08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XOMAPXOMA Corporation
16/02/202414h00GlobeNewswire Inc.XOMA Enters into Agreement to Acquire Kinnate Biopharma for Between $2.3352 and $2.5879 in Cash Per Share Plus a Contingent Value RightNASDAQ:XOMAPXOMA Corporation
 Showing the most relevant articles for your search:NASDAQ:XOMAP

Kürzlich von Ihnen besucht

BIT
SWORLD
SG Issuer Societe Generale
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten